Stockreport

Capricor's lead candidate CAP-1002 shows positive effect on heart function in young men with advanced DMD; shares ahead 25% premarket [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Capricor's lead candidate CAP-1002 shows positive effect on heart function in young men with advanced DMD; shares ahead 25% premarketCapricor Therapeutics (NASDAQ:CAPR) [Read more]